Enovis Corp
ENOV
Market Cap$2.81B
Close$
$-7.89
115.6% downside
Current Fair Value
115.6% downsideOvervalued by 115.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $2.81 Billion |
|---|---|
| Enterprise Value | $3.24 Billion |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-0.61 |
| Beta | 1.14 |
| Outstanding Shares | 54,850,906 |
| Avg 30 Day Volume | 550,827 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -84.55 |
|---|---|
| PEG | 78.52 |
| Price to Sales | 1.63 |
| Price to Book Ratio | 0.82 |
| Enterprise Value to Revenue | 1.9 |
| Enterprise Value to EBIT | -67.02 |
| Enterprise Value to Net Income | -98 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.14 |
Revenue Sources
No data
ESG Score
No data
About Enovis Corp
15,400 employees
CEO: Matthew Trerotola Colfax Corporation is a leading diversified technology company that provides specialty medical technologies and fabrication technology products and services to customers around the world, principally under the DJO and ESAB brands. Colfax...